One-Pot Synthesis of Naphthalen-2-Thiazolidinones as Potential Breast Cancer Therapeutics: An Integrative Approach Using Network Pharmacology, Biomolecular Simulations and in Vitro Evaluation

C. N. Babu Mazin Aboobaida Abdalla Abdelaziz N. Nizamuddin R. Osmani G. Ravi G. Supriya Chagaleti Bharath Kumar Kesavan Bhaskar Reddy Umme Hani Singirisetty Triveni

Aug 2026 · Journal of Pharmaceutical Innovation · Vol 22 · 0 citations · 86 references

TL;DR

Overall, the moderate promising leads of NT1 and NT9 emerged with dual-target potential for breast cancer, supporting further optimization and preclinical assessment.

DOI Semantic Scholar

View source

Similar papers

Sep 2026

Mechanistic Insights into Breast Cancer Targeting by 2-Oxo-2H-Chromene-7-yl 3-Methylbutanoate: An Integrated Computational Study

This in silico study suggests that CMBA warrants further investigation as a potential lead compound for breast cancer–related drug discovery, however, further experimental validation through in vitro and in vivo studies is required to confirm its predicted biological activity and therapeutic relevance.

A. Manikumar, K. M. M. Sheriff, Aravinth Annamalai et al. · Journal of Pharmaceutical In... · 0 citations

Open access Sep 2026

Quinoline clubbed triazole hybrids as VEGFR-2 targeted anticancer agents: synthesis, molecular modeling, and biological evaluation

Findings highlight quinoline–triazole hybrid SVI08 as a preliminary lead to the further optimization as a VEGFR-2-targeted anticancer agents as well as acceptable ADMET properties and good in vivo tolerability up to 50 mg/kg.

Divyanshi Thakur, Mangaldip Ghosh, Shivam Nag et al. · In Silico Pharmacology · 0 citations

Aug 2026

Prenylated 4-Hydroxycoumarin derivatives as inducers of CDK4/6-mediated cell cycle arrest: From design and synthesis to in vitro and in vivo evaluation of their anti-breast Cancer activity.

PB1-3 represents a promising prenylated coumarin lead that orchestrates both CDK4/6-Rb cell cycle checkpoint blockade and ROS-dependent mitochondrial apoptosis, offering a valuable scaffold for developing targeted breast cancer therapies, especially for TNBC.

Xinyao Pan, Shiyu Wang, Kaifeng Lai et al. · Bioorganic chemistry (Print) · 0 citations

Open access Aug 2026

Novel benzofuran-furan-pyrano[2,3-c]pyrazole hybrids as potential anticancer agents: design, synthesis, in silico profiling, and multi-mechanistic biological evaluation

It is demonstrated that benzofuran-furan-pyrano[2,3-c]pyrazole hybrids possess promising multifaceted in vitro anticancer activity by inhibiting cancer cell proliferation, migration, invasion, and clonogenicity while inducing ROS-mediated mitochondrial apoptosis, highlighting these hybrid scaffolds as attractive candid...

E. Hutanu, Bassam A. Najri, A. Abdelsalam et al. · RSC Advances · 0 citations

Open access Sep 2026

Design, synthesis, and molecular modeling of quinoline-linked diphenylpyrazoles as multitarget EGFR, VEGFR-2, and COX-2 inhibitors with anticancer, anti-inflammatory and apoptosis-inducing properties.

A new series of quinoline-diphenylpyrazole hybrids were rationally designed, synthesized, and biologically evaluated as potential EGFR/VEGFR-2/COX-2 inhibitors, supporting the proposed hybrid design strategy.

Abdelrahman Hamdi, Mohamed R. Elnagar, M. Hussein et al. · Bioorganic chemistry (Print) · 0 citations

Open access Sep 2026

Anilino-1,4-naphthoquinone derivatives exhibit antiproliferative, anti-inflammatory, and pro-apoptotic activities in LPS-stimulated SW480 colorectal cancer cells: In vitro and in silico studies.

Findings establish compound 12 as a promising lead candidate for the development of new anti-colorectal cancer agents and provide mechanistic insights into the interplay between COX-2 inhibition, inflammatory modulation, and apoptosis induction in inflammation-associated colorectal carcinogenesis.

Sakdiphong Punpai, Panupong Mahalapbutr, Panyakorn Taweechat et al. · Biomedicine & pharmacotherap... · 0 citations